TIGIT and neoplasm: Tumor exposure alone or with TIGIT blockade did not change the frequency of NK cells expressing inhibitory receptors TIM-3, NKG2A, LAG-3, PD-1, or CD96 compared to isotype control or unexposed NK cells (Supplementary Figure S7).